Drug Trial Radar · NCT00324805
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,501
Actual
Start
Jul 19, 2007
Primary completion
Oct 20, 2015
Study completion Jan 31, 2025
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- Collaborators
- Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group; SWOG Cancer Research Network
- First posted
- May 11, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies chemotherapy and bevacizumab to see how well they work compared to chemotherapy alone in treating patients with stage IB, stage II, or stage IIIA non-small cell lung cancer that was removed by surgery. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Bevacizumab also may stop the growth of non-small cell lung cancer by blocking the growth of new blood vessels necessary for tumor growth. It is not yet known whether chemotherapy is more effective with or without bevacizumab in treating non-small cell lung cancer.
Conditions
- Stage IB Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIA Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Interventions
BevacizumabBiological
Given IV
CisplatinDrug
Given IV
DocetaxelDrug
Given IV
Gemcitabine HydrochlorideDrug
Given IV
Laboratory Biomarker AnalysisOther
Correlative studies
Pemetrexed DisodiumDrug
Given IV
Questionnaire AdministrationOther
Ancillary studies
Vinorelbine TartrateDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: From registration to death, up to 10 years
Locations
1,169 sites in 5 countries. Site status is shown where the registry gives one.
Northeast Alabama Regional Medical Center
Anniston, Alabama
Clearview Cancer Institute
Huntsville, Alabama
Providence Hospital
Mobile, Alabama
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama
Alaska Regional Hospital
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Mayo Clinic in Arizona
Scottsdale, Arizona
University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
University of Arizona Cancer Center-North Campus
Tucson, Arizona
Mercy Hospital Fort Smith
Fort Smith, Arkansas
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
NEA Baptist Memorial Hospital
Jonesboro, Arkansas
Saint Bernards Regional Medical Center
Jonesboro, Arkansas
John L McClellan Memorial Veterans Hospital
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Kaiser Permanente-Anaheim
Anaheim, California
Kaiser Permanente-Deer Valley Medical Center
Antioch, California
PCR Oncology
Arroyo Grande, California
Kaiser Permanente-Baldwin Park
Baldwin Park, California
Kaiser Permanente-Bellflower
Bellflower, California
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mills-Peninsula Medical Center
Burlingame, California
East Bay Radiation Oncology Center
Castro Valley, California
Eden Hospital Medical Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
Adventist Health Cancer Care Center Chico
Chico, California
Community Cancer Institute
Clovis, California
City of Hope Comprehensive Cancer Center
Duarte, California
Bay Area Breast Surgeons Inc
Emeryville, California
Epic Care Partners in Cancer Care
Emeryville, California
Kaiser Permanente-Fontana
Fontana, California
Kaiser Permanente-Fremont
Fremont, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
California Cancer Associates for Research and Excellence (cCare)
Fresno, California
Kaiser Permanente-Fresno
Fresno, California
Saint Jude Medical Center
Fullerton, California
Glendale Memorial Hospital and Health Center
Glendale, California
Marin Cancer Care Inc
Greenbrae, California
Showing 40 of 1,169 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.